Get in Touch



SL-5234

Montelukast EP impurity B, >98%

CAS No. : 
[918972-54-0]    
Synonyms : [1-[[[(1R)-1-[3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(prop-1-en-2- yl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetic acid; Montelukast USP related compound F; Montelukast methylstyrene; Anhydromontelukast; Dehydro montelukast; Styrene montelukast

Price and Availability
Pack Size Price in USD Quantity Availability Shipping Status
5MG580.00 Back Order Estimated to Ship on 05.26.2024
10MG980.00 Back Order Estimated to Ship on 05.26.2024
Chemical Properties
C35H34ClNO2S 568.17
Solid Not available
For Laboratory research use only, not for drug, household or other uses.
Applications : This is an impurity of Montelukast (Montelukast EP impurity B), which is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
References : Zhang Y. J. et al.: Acta Pharmacol Sin, 25(10), 1341-1346, 2004.
Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.
Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.

If you login prior to completion of the form, your contact information will automatically populate.

Your request for quote will also be accepted by e-mail at sales@syninnova.com or Fax: +1 780 485 2963.

Product ID : SL-5234

Product Name : Montelukast EP impurity B

Note : If you do not find your required compound in our catalogue, or not commercially available, please contact us, we will assist you to get your desired molecule. We only charge if we deliver to your satisfaction.

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!